Surveys: Clinical Trials

35 trials of Surveys, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

19 completed, 7 terminated, 5 active not recruiting, 4 withdrawn. 35 Phase 2, 7 Phase 1, 2 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 235Completed 19, Terminated 7, Active not recruiting 5, Withdrawn 4
Phase 17Completed 4, Active not recruiting 1, Terminated 1, Withdrawn 1
Phase 32Completed 2

Follow Surveys: new trials by email Literature Review of Surveys trials Research Report on Surveys

Trials (filtered) newest first · largest first

All 35 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Pneumoperitoneum Management With Low vs. Higher Pressure
Questionnaires, Conventional Insufflation System (CIS), ConMed AirSeal Insufflation System (AIS) at Low Pressure - Malignant Neoplasms of Female Genital Organs
Phase 2WithdrawnM.D. Anderson Cancer Center2018-07-012019-05-30
Single Versus Multifraction Salvage Spine Stereotactic Radiosurgery for Previously Irradiated Spinal Metastases
Spine Radiosurgery, Questionnaires - Malignant Neoplasms of Eye Brain and Other Parts of Central Nervous System
Phase 2Active not recruitingM.D. Anderson Cancer Center802017-01-182026-09-14
Effects of Social Networking on Chronic Disease Management in Arthritis
Questionnaires, Facebook, Educational Website - Chronic Disease Management, Rheumatoid Arthritis
Phase 2 / Phase 3CompletedM.D. Anderson Cancer Center2102016-04-072023-06-18
SINF: Peripheral Neuropathy in Cancer Survivors
Acupuncture, Nerve Function Tests, Questionnaires - Peripheral Neuropathy
Phase 1 / Phase 2WithdrawnM.D. Anderson Cancer Center2016-03-012016-03-08
Sublingual Fentanyl for the Management of Breakthrough Pain
Fentanyl Sublingual Spray (FSS), Questionnaires, Mental Ability Tests - Advanced Cancers
Phase 2TerminatedM.D. Anderson Cancer Center62016-02-022021-05-18
Fentanyl Sublingual Spray for Exercise-Induced Breakthrough Dyspnea
Fentanyl Sublingual Spray, Shuttle Walk Test, Questionnaires - Advanced Cancers
Phase 2 / Phase 3CompletedM.D. Anderson Cancer Center502016-01-042021-02-09
Project Impact 2: A Culturally Tailored Smoking Cessation Intervention for Latino Smokers
Nicotine Patch, Questionnaires, Carbon Monoxide (CO) Test - Tobacco Use Cessation, Cancer Prevention
Phase 1 / Phase 2CompletedM.D. Anderson Cancer Center262015-11-022020-03-10
Metformin for Reduction of Paclitaxel-Related Neuropathy in Patients With Breast Cancer
Metformin, Placebo, Questionnaires - Breast Cancer
Phase 2TerminatedM.D. Anderson Cancer Center12015-10-012017-08-17
Pacritinib Before Transplant for Myeloproliferative Neoplasms (MPN)
Pacritinib, Busulfan, Questionnaires - Myeloproliferative Diseases
Phase 2TerminatedM.D. Anderson Cancer Center42015-06-152018-10-30
Robotic Surgery for Oropharyngeal Squamous Cell Carcinoma
Transoral Robotic Surgery (TORS), Modified Barium Swallow (MBS), Questionnaires - Oropharyngeal Cancer
Phase 2TerminatedM.D. Anderson Cancer Center12014-09-232017-12-15
Study of Valproic Acid (VPA) vs Placebo to Shorten Time of Indwelling Pleural Catheter
Placebo, Valproic Acid (VPA), Questionnaires - Breast Cancer
Phase 2TerminatedM.D. Anderson Cancer Center32014-07-312020-02-25
Acupuncture Chemotherapy-Induced Peripheral Neuropathy (CIPN) IRG
Acupuncture, Questionnaires, Hand Function and Balance Tests - Breast Cancer
Phase 1 / Phase 2TerminatedM.D. Anderson Cancer Center42014-07-062018-01-12
Fentanyl Buccal Tablets for Exercise Induced Breakthrough Dyspnea
Fentanyl Buccal Tablet, Placebo Buccal Tablet, Questionnaires - Advanced Cancers
Phase 2CompletedM.D. Anderson Cancer Center362014-05-272020-09-16
Minocycline for Postsurgical Symptom Reduction in Head and Neck Cancer
Minocycline, Placebo, Questionnaires - Head And Neck Cancer
Phase 2TerminatedM.D. Anderson Cancer Center302014-05-062022-10-20
Haloperidol and Lorazepam for Delirium in Patients With Advanced Cancer
Lorazepam, Placebo, Haloperidol decanoate - Advanced Cancers
Phase 2Active not recruitingM.D. Anderson Cancer Center932014-01-012026-07-17
Study of Chemotherapy With Cisplatin/Carboplatin, and Docetaxel With or Without Erlotinib in Patients With Head and Neck Squamous Cell Carcinomas Amenable for Surgical Resection
Docetaxel, Erlotinib, Placebo - Head and Neck Cancer
Phase 2CompletedM.D. Anderson Cancer Center552013-12-162025-11-26
BiPAP-Vapotherm RCT
Oxygen Delivery Devices, Questionnaires - Advanced Cancers
Phase 2WithdrawnM.D. Anderson Cancer Center2013-12-012013-08-13
Phase II Study of Minocycline for Reducing Symptom Burden in Colorectal Patients
Minocycline, Placebo, Questionnaires - Colorectal Cancer
Phase 2CompletedM.D. Anderson Cancer Center1222013-11-012020-03-17
Fentanyl Pectin Nasal Spray (FNPS) for Exercise-Induced Breakthrough Dyspnea
Fentanyl Pectin Nasal Spray, Placebo Nasal Spray, Walk Test - Advanced Cancers
Phase 2CompletedM.D. Anderson Cancer Center352013-06-112023-06-08
Glioblastoma Multiforme (GBM) Proton vs. Intensity Modulated Radiotherapy (IMRT)
IMPT, IMRT, Cognitive Tests - Brain Cancer
Phase 2CompletedM.D. Anderson Cancer Center902013-05-172024-01-02

Showing 20 of 35. Sign in to see all of them.

Conditions studied

Neoplasm Metastasis (6)  ·  cyclopia sequence (6)  ·  Dyspnea (5)  ·  Breast Neoplasms (4)  ·  Head and Neck Neoplasms (3)  ·  Carcinoma, Squamous Cell (2)  ·  Esophageal Neoplasms (2)  ·  Multiple Myeloma (2)  ·  Neoplasms, Plasma Cell (2)  ·  Recurrence (2)  ·  Adenocarcinoma (1)  ·  Agnosia (1)  ·  Arthritis, Rheumatoid (1)  ·  Brain Neoplasms (1)  ·  Bronchiolitis Obliterans Syndrome (1)

Sponsors

M.D. Anderson Cancer Center (34)  ·  Memorial Sloan Kettering Cancer Center (1)

Countries

United States (31)  ·  Canada (1)

Top investigators

David Hui, MD (7)  ·  Abenaa M. Brewster, MD, MHS, BS (1)  ·  Amado Zurita, MD (1)  ·  Amol J. Ghia, MD (1)  ·  Angeles M. Lopez-Olivo, MD, PHD, MS (1)  ·  Brian F. Chapin, MD (1)  ·  Caroline Chung, MD (1)  ·  Cathy Eng, MD, BA (1)  ·  David Fogelman, MD (1)  ·  David L. Ramirez, MD (1)  ·  Francesca Gany, MD, MS (1)  ·  Gary B. Gunn, MD (1)  ·  Jatin J. Shah, MD (1)  ·  Juan P. Cata, MD (1)  ·  Kay Garcia, DRPH (1)

Results publications

PMID 23739633, PMID 23830530, PMID 27330023, PMID 27401508, PMID 28874596, PMID 28975307, PMID 30633744, PMID 32160096, PMID 35709430, PMID 35872394, PMID 37146227, PMID 37652304

NIH funding

R01CA026582 (3), K01CA160670 (1), P01CA124787 (1), R21CA158902 (1), R21CA186000 (1), U19CA021239 (1)